PECURA Technology Co., Ltd.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
PECURA Technology Co., Ltd. Peripheral Vascular Health Assessment Device: Integrates multi-point synchronized physiological signal measurement technology to convert indicators related to blood flow and vascular elasticity into easily understandable data, enabling a rapid, repeatable, and long-term trackable vascular health assessment process.
The content above was translated by Ai
Founded Year
2025
Unified Business No.
82970237
Status
Active
Number of Employees
2
Total Paid-in
Capital
16,380,000 (NT$)
Location of Company
Taiwan
, Tainan City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
PECURA Technology Co., Ltd. is a medical technology company focusing on the development of non-invasive smart vascular monitoring systems, dedicated to creating faster, more accurate, and easy-to-use vascular health assessment tools through innovative sensing technology, AI analysis, and cloud-based health management platforms. PECURA's products are designed for the early screening and long-term monitoring of peripheral arterial disease (PAD), simultaneously measuring PPG and ECG signals through limb clamps to provide clinical-grade vascular stiffness indices and peripheral vascular risk assessments within approximately one minute. With "portability, cuffless design, and low operational threshold" at its core, combined with motion artifact-resistant signal processing, AI analysis, and cloud trend tracking, it extends vascular health management from hospitals to clinics, long-term care centers, pharmacies, telehealth, and home settings.
The content above was translated by Ai
